Exxsun Corp (MNZO)
Exxsun Corp (MNZO) is listed on OTC Markets as common stock and is associated with a healthcare business focused on pharmaceuticals. The company description identifies specialty pharmaceutical activities centered on researching, developing, and testing patented and non-patented solutions and remedies. Its reported pipeline includes Lacto-Freedom, a patented probiotic intended to help people digest lactose-containing foods, as well as a natural remedy being developed for infant colic. The business was previously known as Fortune Oil & Gas, Inc. and adopted the Manzo Pharmaceuticals, Inc. name in September 2014. Incorporated in 1980, the company is based in Milford, Pennsylvania.
Jump between the core stock analysis sections, valuation data, fair value models, technical outlook, and FAQ.
| Ticker | Fair Value | Fair Value Upside/Downside | Fair Value Rating | Analyst Price Target | Analyst Target Upside/Downside | Analyst Target Rating | Overall Financial Health | Upcoming Dividend Ex-Date | Dividend Payment Date | Upcoming Dividend | Dividend Yield | Next Earnings Date | P/E Ratio | Price-to-Book Ratio | Price-to-Sales Ratio | Market Cap | Enterprise Value | Total Debt / Total Capital | Free Float / Shares Outstanding | Altman Z-Score | Payout Ratio | Free Cash Flow / Net Income |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
OTC-MNZO
|
—
|
—
|
—
|
—
|
—
|
—
|
Excellent
|
—
|
—
|
—
|
0.0%
|
—
|
—
|
—
|
—
|
109.952 K
|
—
|
—
|
—
|
—
|
—
|
—
|